Navigation Links
At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed)

y Rat Neurons by a GABA-Independent Pathway in presentation P-192. About Neurochem

Neurochem Inc. is focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs. Eprodisate (KIACTA(TM)) is currently being developed for the treatment of Amyloid A (AA) amyloidosis, and is under regulatory review for marketing approval by the United States Food and Drug Administration, European Medicines Agency and Swissmedic. Tramiprosate (ALZHEMED(TM)), for the treatment of Alzheimer's disease, has completed a Phase III clinical trial in North America and is currently in a Phase III clinical trial in Europe, while tramiprosate (CEREBRIL(TM)), for the prevention of Hemorrhagic Stroke caused by Cerebral Amyloid Angiopathy, has completed a Phase IIa clinical trial.

To Contact Neurochem

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1 877 680-4500 or visit our Web Site at: www.neurochem.com.

This news release contains forward-looking statements regarding tramiprosate (ALZHEMED(TM)) as well as regarding continuing and further development efforts. These statements are based on the current analysis and expectations of management. Drug development necessarily involves numerous risks and uncertainties, which could cause actual results to differ materially from this current analysis and these expectations. Analysis regarding the results of clinical trials may not provide definitive results regarding safety, tolerability or therapeutic benefits. Even if all the endpoints sought in the clinical trials were met (which is not certain), there is no certainty that regulators would ultimately approve tramiprosate (ALZHEMED(TM)) for sale to the public. Risks and uncertainties may include: failure to demonstrate the safety, tolerability and efficacy of our product, that ac
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
6. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
7. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
8. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
9. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
10. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
11. Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimers Drug
Post Your Comments:
(Date:4/21/2015)... April 21, 2015  Legal-Bay LLC, The Lawsuit ... Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for ... According to PBR, Boehringer submitted a supplemental new ... that Pradaxa will be approved for the prophylaxis ... (PE) for patients who have undergone a primary ...
(Date:4/20/2015)... is the daily "Profile America" feature from the U.S. ... Profile America — Tuesday, April 21st. One ... for general use this month in 1923, saving the ... is a hormone produced by the pancreas and is ... body. It was first isolated the year before by ...
(Date:4/20/2015)... Gregory Taylor , Canada,s Chief Public Health ... a week in West Africa . The visit ... the ground as global efforts continue to reach zero Ebola cases. ... in Sierra Leone and Guinea ... work being done and hear from those on the front-lines about ...
Breaking Medicine Technology:Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 2Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE 3U.S. Census Bureau Daily Feature for April 21 2Canada's Efforts Making a Difference in the Fight Against Ebola 2Canada's Efforts Making a Difference in the Fight Against Ebola 3Canada's Efforts Making a Difference in the Fight Against Ebola 4Canada's Efforts Making a Difference in the Fight Against Ebola 5
... and CARLSBAD, Calif., Aug. 6 ,Genzyme Corp. (Nasdaq: ... ),today announced that they have begun a phase 3 ... a genetic,disorder that causes exceptionally high levels of LDL ... companies plan to initiate by the end of,this year, ...
... the most recent issue of,Optometry & Vision Development, two ... Fischer and his team which found,that children with vision ... that if the appropriate vision therapy is given,math skills ... several German television news,programs which reported on his research ...
Cached Medicine Technology:Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 2Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 3Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 4Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 5Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 6Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 7Vision Problems Affect How Children Learn Math Skills 2
(Date:4/21/2015)... On Saturday, May 2nd, 2015, board certified ophthalmologist ... from Georgia Eye Physicians and Surgeons will ... held in Piedmont Park by the Lupus Foundation of ... largest LFA-sponsored walk in the nation, hosting more than ... awareness for lupus, an unpredictable and potentially fatal autoimmune ...
(Date:4/21/2015)... Antonio, TX (PRWEB) April 21, 2015 ... rights from a prestigious Illinois university for a ... care units (NICUs) more conducive to newborn infants’ ... the top three NICU problems we have identified ... neonatal care professionals,” said George Hutchinson, Invictus Medical’s ...
(Date:4/21/2015)... 2015 “The warm summer season is fast ... want to look younger than her age? In the ... of defense. Signs of premature aging are deep ... too much time spent in the sun without adequate protection.” ... up. The dangers of UV rays can go deep ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Heritage Woods ... host an Open House and Dine-and-Dash Spaghetti Dinner from ... The community, which is located in Centralia, Illinois, houses ... homes for low-income adults 55 and older. , Guests ... staff about supportive living options for seniors. After the ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Using Quality ... CMOs Speed Production and Improve Compliance , **FDAnews Webinar**, ... EDT, http://www.fdanews.com/qualitybydesign , The life sciences industries ... them to do more with less. Mergers, acquisitions, ... CMOs to finds ways to speed up production while ...
Breaking Medicine News(10 mins):Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3
... from various poultry farms across the state of Chattisgarh ... ,"Chhattisgasrh has not a single bird flu case ... at the High Security Animal Disease Lab at Bhopal," ... ,An official statement Thursday said the state government had ...
... Online counseling through Internet is gaining momentum slowly but surely ... practitioner// and discuss problems of any sort, as they do ... ,If the person being talked to is not visible, it ... or problems. ,"Psychotherapy is treatment for mental or ...
... Centers for Disease Control and Prevention highlights that very ... and contradicts the widely held public perception which blames ... ,The study for the first time challenges the ... HIV/AIDS, among the Blacks. The researchers of the present ...
... has caused the health officials to request the airlines ... Disease Control and Prevention have asked them to collect ... contact numbers and detailed flight information, to help track ... an additional expenditure on the airlines which is already ...
... various organizations are putting in their effort to combat the ... of the disease from the face of the earth. One ... India, and asked all the non-governmental organizations (NGOs) who are ... work as a unit. It asked them to co operate ...
... U.S. Army Medical Research Institute of Infectious Diseases and ... of Canada reported yesterday that the vaccine that is ... in monkeys after they were exposed to the deadly ... for the infection caused by Ebola virus. ...
Cached Medicine News:Health News:Anonymity Helps In Overcoming Inhibitions During Online Counseling 2Health News:New Vaccine To Combat The Deadly Marburg Virus 2
... The Laserex Ultra Q is the fundamental ... cavity optimizes energy delivery and provides 2855% less ... to 2.54.0 mJs in contemporary systems. This ... dramatically reduces the risk of IOL pitting. ...
... Ultrasonix 500 is a high-end, mobile ultrasound ... architecture provides a tremendous amount of processing ... and resolution. Ultrasonix imaging systems provide ... including B, B/M, Pulsed Doppler, Color Doppler ...
Protects the eye during or after surgery or trauma. Clear window dressing. Protects the eye allowing the patient to see....
Protects the eye during or after surgery or trauma. 8mm diameter, lint free keeps cornea moist. Protects retina from operating microscope light rays....
Medicine Products: